NCT02652585View on ClinicalTrials.gov

Validation of a Test System for Development of Medications for Alcoholism

PHASE3CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

August 25, 2017

Study Completion Date

September 4, 2017

Conditions
Alcoholism
Interventions
DRUG

Naltrexone

DRUG

Placebo

capsule filled with micro crystalline cellulose, manufactured to mimic naltrexone capsule

Trial Locations (1)

01307

Klinik und Poliklinik für Psychiatrie und Psychotherapie, Dresden

All Listed Sponsors
lead

Technische Universität Dresden

OTHER

NCT02652585 - Validation of a Test System for Development of Medications for Alcoholism | Biotech Hunter | Biotech Hunter